$214 Million is the total value of Essex Woodlands Management, Inc.'s 8 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EYPT | EYEPOINT PHARMACEUTICALS INC | $64,959,000 | -14.4% | 41,909,219 | 0.0% | 30.30% | -35.9% | |
| RVNC | REVANCE THERAPEUTICS INC | $54,241,000 | +24.8% | 3,342,047 | 0.0% | 25.30% | -6.5% | |
| AXGN | AXOGEN INC | $43,473,000 | +43.4% | 2,429,999 | 0.0% | 20.28% | +7.3% | |
| VERO | New | VENUS CONCEPT INC | $32,984,000 | – | 7,017,856 | +100.0% | 15.38% | – |
| TELA | New | TELA BIO INC | $9,962,000 | – | 769,231 | +100.0% | 4.65% | – |
| MNOV | Sell | MEDICINOVA INC | $7,531,000 | -21.1% | 1,117,355 | -4.5% | 3.51% | -40.9% |
| ELGXQ | ENDOLOGIX INC | $717,000 | -28.2% | 125,747 | 0.0% | 0.33% | -46.3% | |
| CBIO | CATALYST BIOSCIENCES INC | $535,000 | +38.6% | 78,622 | 0.0% | 0.25% | +4.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDICINOVA INC | 42 | Q3 2023 | 6.5% |
| REVANCE THERAPEUTICS INC | 39 | Q3 2023 | 44.6% |
| AXOGEN INC | 26 | Q4 2021 | 43.3% |
| ENDOLOGIX INC | 24 | Q1 2019 | 22.5% |
| ABIOMED INC | 20 | Q1 2018 | 52.1% |
| CORIUM INTL INC | 20 | Q1 2019 | 23.5% |
| TELA BIO, INC. | 16 | Q3 2023 | 31.5% |
| VENUS CONCEPT, INC. | 16 | Q3 2023 | 21.3% |
| ACURA PHARMACEUTICALS INC | 15 | Q1 2019 | 1.4% |
| CATALYST BIOSCIENCES INC | 15 | Q1 2019 | 1.0% |
View Essex Woodlands Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Essex Woodlands Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.